http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Tai-Min Cheng,Yan-Ming Ma,Chong-Yuan Ge,Shu-Sheng Sun,Wei-Ye Jia,Qing-Yun Li,Xiao-Fei Shi,Lin Li,Lin Zhu 한국물리학회 2013 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.62 No.1
The elementary excitation spectra of a one-dimensional ferrimagnetic diamond chain in the spin- 1/2 XY model at low temperatures have been calculated by using an invariant eigen-operator (IEO) method, the energies of elementary excitations in different specific cases are discussed, and the analytic solutions of three critical magnetic field intensities (<i>H</i><sub>C1</sub>, <i>H</i><sub>C2</sub>, and <i>H</i><sub>peak</sub>) are given. The magnetization versus external magnetic field curve displays a 1/3 magnetization plateau at low temperatures, in which <i>H</i><sub>C1</sub> is the critical magnetic field intensity from the disappearance of the 1/3 magnetization plateau to spin-flop states, <i>H</i><sub>C2</sub> is the critical magnetic field intensity from spin-flop states to the saturation magnetization, and Hpeak is the critical magnetic field intensity when the temperature magnetization shows a peak in the external magnetic field. The temperature dependences of the magnetic susceptibility and the specific heat show a double peak structure. The entropy and the magnetic susceptibility versus external magnetic field curves also exhibit a double peak structure, and the positions of the two peaks correspond to <i>H</i><sub>C1</sub> and <i>H</i><sub>C2</sub>, respectively. This derives from the competition among different types of energies: the temperature-dependent thermal disorder energy, the potential energy of the spin magnetic moment, the ferromagnetic exchange interaction energy, and the anti-ferromagnetic exchange interaction energy. However at low temperatures, the specific heat as a function of external magnetic field curve exhibits minima at the above two critical points (<i>H</i><sub>C1</sub> and <i>H</i><sub>C2<sub>). The origins of the above phenomena are discussed in detail.
Ma, Dong Hee,Kim, Dokyoung,Akisawa, Takuya,Lee, Kyung-Ha,Kim, Kyong-Tai,Ahn, Kyo Han Wiley-VCH 2015 Chemistry - An Asian Journal Vol.10 No.4
<P>A novel FRET couple of fluorescein is disclosed, and it was readily constructed by conjugating an amino-BODIPY dye, a new FRET donor, with fluorescein isocyanate. Its potential was demonstrated by a fluorescence sensing system for cysteine, which was prepared by introducing acryloyl groups to the fluorescein moiety. The FRET probe exhibited promising ratiometric response to cysteine with high selectivity and sensitivity in a buffer solution containing acetonitrile at a physiological pH of 7.4, but showed slow reactivity. This slow response was solved by addition of a surfactant, thus allowing ratiometric imaging and determination of the endogenous level of cysteine in cells in HEPES buffer, by confocal fluorescence microscopy. Imaging experiments toward various cells suggested that such aryl acrylate type probes are vulnerable to the ubiquitous esterase activity. For the selected C6 cell line, in which the esterase activity was minimal, the ratiometric quantification of cysteine level was demonstrated. The FRET probe was also applied to determine the level of cysteine in human blood plasma.</P>
Ma, Long,Zhu, Wen-Zhen,Liu, Ting-Ting,Fu, Hui-Ling,Liu, Zhao-Jun,Yang, Bing-Wu,Song, Tai-Yu,Li, Guo-Rong Asian Pacific Journal of Cancer Prevention 2015 Asian Pacific journal of cancer prevention Vol.16 No.4
Background: RhoGTPase-activating proteins (RhoGAPs) regulate RhoGTPases in cells, but whether individual reactive oxygen species (ROS) regulate RhoGAPs is unknown. Our previous published papers have shown that deleted in liver cancer 1 (DLC1) inhibits cancer cell migration by its RhoGAP activity. The present study was designed to explore the role of $H_2O_2$ in regulation of DLC1. Materials and Methods: We treated cells with $H_2O_2$ for 24h and phenotypic changes were analyzed by MTT, RT-PCR, Western blotting, immunofluorescence staining and wound healing assays. Results: $H_2O_2$ downregulated cyclin D1 and cyclin E to inhibit proliferation, and upregulated BAX to induce apoptosis in MCF-7 cells. Compared with non-tumorigenic cells, $H_2O_2$ increased expression of DLC1 and reduced activity of RhoA in cancer cells. Stress fiber production and migration were also suppressed by $H_2O_2$ in MDA-MB-231 cells. Conclusions: Our study suggests that $H_2O_2$ inhibits proliferation through modulation of cell cycle and apoptosis-related genes, and inhibits migration by decreasing stress fibers via DLC1/RhoA signaling.
Human HS1BP3 induces cell apoptosis and activates AP-1
( Tai Ping Shi ),( Jie Shi Xie ),( Ying Xiong ),( Wei Wei Deng ),( Jin Hai Guo ),( Feng Wang ),( Da Long Ma ) 생화학분자생물학회(구 한국생화학분자생물학회) 2011 BMB Reports Vol.44 No.6
In the present study, we characterized the function of HS1-binding protein 3 (HS1BP3), which is mutated in essential tremor and may be involved in lymphocyte activation. We found that HS1BP3 localized to the mitochondria and endoplasmic reticulum partially. Overexpression of HS1BP3 induced apoptosis in HEK293T and HeLa cell lines. When these cell lines were transfected with HS1BP3, they exhibited nuclear DNA condensation, externalization of phosphatidylserine (PS), and cleavage of poly ADP ribose polymerase (PARP). Furthermore, suppression of HS1BP3 or HS1 expression attenuates HS1BP3 induced apoptosis. In addition, HS1BP3 enhanced activator protein 1 (AP-1)-mediated transcription in a dose-dependent manner. Therefore, we conclude that HS1BP3 regulates apoptosis via HS1 and stimulates AP-1-mediated transcription. [BMB reports 2011; 44(6): 381-386]
소아과 영역 감염증에 대한 SAGACIN의 임상적 연구
마재숙,최영륜,황태주,손철 대한화학요법학회 1985 대한화학요법학회지 Vol.3 No.1
SAGACIN is a new aminoglycoside antibiotic with a broad spectrum of antimicrobial activity smilar to that of gentamicin. The clinical studies on SAGACIN were performed in the pediatric field and following results were obtained. 1) SAGACIN was administered intramuscularly to 30 pediatric patients who had bacterial infections: 12 cases with urinary tract infections and 18 cases with pneumonias. The therapeutic results in 12 cases with urinary tract infections were excellent in 6 cases) good in 3, fair in I and poor in 2, and the clinical effectiveness rate (defined as the sum of excellent and good response) was 75.0%. In the 18 cases with pneumonias, the clinical response was excellent in 4 cases, good in 9, fair in 1 and poor in 4, and the clinical effectiveness rate(defined as the sum of excellent and good response) was 72.2%. The overall clinical effectiveness rate (defined as the sum of excellent and good response) in the total 30 patients was 73.3%. In the bacteriological results, the eradicative effects on causative organisms in urinary tract infections and pneumonias were seen in 66.67% a:nd 55.55% respectively, and the overall eradicative effect on causative organisms in the total 30 patients was 60.0%. 2) No side effects were observed and there were no abnormalities in the laboratory findings of complete blood count, liver function tests, urinalysis, BUN and creatinine level.